lamivudine_zidovudine: profile and news

International Approvals: Sifrol/Mirapexin and Truvada  Apr 24, 2006
The approval was based on data from a 48-week study that compared a once-daily regimen of tenofovir/emtricitabine with twice-daily lamivudine/zidovudine, 150 mg ... - Medscape (subscription)

Gilead Sciences Announces First Quarter 2006 Financial Results  Apr 18, 2006
Study 934) comparing a once-daily treatment regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir(R) (lamivudine/zidovudine) with Sustiva ... - Genetic Engineering News,